awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34026630-620F2775-3ADB-4870-8182-D83507EDDA2F
Q34026630-620F2775-3ADB-4870-8182-D83507EDDA2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34026630-620F2775-3ADB-4870-8182-D83507EDDA2F
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
P2860
Q34026630-620F2775-3ADB-4870-8182-D83507EDDA2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34026630-620F2775-3ADB-4870-8182-D83507EDDA2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e21c38a31f5d97ca5e80a82812ed4807ddf4504e
P2860
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.